文献速递神经MRPET

MRI与PET作为脑转移瘤患者立体定向放射外科治疗后治疗反应潜在替代终点的比较

Comparison of MRI and PET as Potential Surrogate Endpoints for Treatment Response After Stereotactic Radiosurgery in Patients With Brain Metastasis.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

该系统综述纳入20项研究共728例患者872个脑转移灶,比较MRI与PET鉴别肿瘤复发与放射性坏死的诊断性能。MRI合并敏感度84%、特异度88%,PET合并敏感度84%、特异度86%,两者诊断性能无统计学显著差异(间接比较p=0.80,直接比较p=0.48)。先进MRI诊断性能显著高于常规MRI(p=0.01),且先进MRI(敏感度86%、特异度95%)显著高于PET(p<0.01)。

要点

  • MRI与PET鉴别脑转移瘤立体定向放射外科治疗后肿瘤复发与放射性坏死的诊断性能无显著差异。
  • 先进MRI(灌注MRI)诊断性能显著高于常规MRI(p=0.01)及PET(p<0.01)。
  • 因研究异质性和数量有限,应用结果时需谨慎。

核心结论

  • MRI和PET对脑转移瘤立体定向放射外科治疗后肿瘤复发的检测均显示高诊断性能,两者间无显著差异;因异质性和研究匮乏,应用结果时可能需谨慎。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid-Medline和Embase数据库至2017年11月11日,纳入20项研究共728例患者872个脑转移灶,采用分层logistic回归模型获得合并敏感度和特异度,并进行Meta回归。

诊断标准与关键数值

  • MRI鉴别肿瘤复发与放射性坏死的合并敏感度84%(95%CI 72-91%)、合并特异度88%(95%CI 71-96%)。
  • PET鉴别肿瘤复发与放射性坏死的合并敏感度84%(95%CI 78-88%)、合并特异度86%(95%CI 81-90%)。
  • MRI与PET诊断性能间接比较p=0.80、直接比较p=0.48,均无统计学显著差异。
  • 先进MRI诊断性能显著高于常规MRI(p=0.01);先进MRI敏感度86%(95%CI 74-93%)、特异度95%(95%CI 82-98%),显著高于PET(p<0.01)。
  • 所有纳入研究均使用灌注MRI作为先进MRI技术。

局限性

  • 因异质性和研究匮乏,应用结果时可能需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to compare the diagnostic performance of MRI and PET for differentiating tumor recurrence from radiation necrosis in patients with brain metastasis treated with stereotactic radiosurgery.

MATERIALS AND METHODS: The Ovid-Medline and Embase databases were searched up to November 11, 2017, to find relevant studies. Pooled sensitivity and specificity from entire included studies were obtained using hierarchic logistic regression modeling. Metaregression was performed.

RESULTS: Twenty studies including 728 patients with 872 brain metastases were selected. MRI showed a pooled sensitivity of 84% (95% CI, 72-91%) and specificity of 88% (95% CI, 71-96%). PET showed a pooled sensitivity of 84% (95% CI, 78-88%) and specificity of 86% (95% CI, 81-90%). There were no statistically significant differences in the diagnostic performance of MRI and PET using indirect (p = 0.80) or direct (p = 0.48) comparisons. The diagnostic performance of advanced MRI was significantly higher than that of conventional MRI (p = 0.01). Advanced MRI (sensitivity, 86% [95% CI, 74-93%]; specificity, 95% [95% CI, 82-98%]) showed a significantly higher diagnostic performance than did PET (p < 0.01). All the included studies used perfusion MRI as an advanced MRI technique.

CONCLUSION: MRI and PET showed high diagnostic performance for the detection of tumor recurrence after stereotactic radiosurgery in patients with brain metastasis. There was no significant difference in the diagnostic performance between MRI and PET. Because of heterogeneity and paucity in studies, caution may be needed in applying the results.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Suh CH, Kim HS, Jung SC, et al. Comparison of MRI and PET as Potential Surrogate Endpoints for Treatment Response After Stereotactic Radiosurgery in Patients With Brain Metastasis. AJR Am J Roentgenol. 2018. PMID: 30240297. doi:10.2214/AJR.18.19674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。